We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Near Death Experience (NDE) and Migraine

This study is not yet open for participant recruitment.
Verified August 2016 by Assistance Publique Hopitaux De Marseille
Sponsor:
ClinicalTrials.gov Identifier:
NCT02854930
First Posted: August 4, 2016
Last Update Posted: August 4, 2016
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
Information provided by (Responsible Party):
Assistance Publique Hopitaux De Marseille
  Purpose
Migraine is a common disabling primary headache disorder. Epidemiological studies have documented its high prevalence and high socio-economic and personal impacts. Migraine affects more than 20% of the French population. However, the physiopathology of migraine is always partially known. Cortical spreading depression (CSD) is the widely accepted as the electrophysiologic substrate of migraine aura. CSD is a slowly propagating wave of transient neuronal and glial depolarization. The near death experience (NDE) is a rare, but well known phenomenon. NDE are profound psychic experiences commonly occuring in life-threatening conditions. Among the neurological hypotheses, epilepsy, temporal lobe disorders , REM-sleep intrusion have been discussed. However, the role of DCE has never been discussed. The goals of this study are : to see if there is an epidemiological link between NDE and migraine/ to specify if NDE was followed by a migrainous headache.

Condition Intervention
Migraine Near Death Experience Other: questioning

Study Type: Observational
Study Design: Time Perspective: Prospective
Official Title: Near Death Experience (NDE) and Migraine

Resource links provided by NLM:


Further study details as provided by Assistance Publique Hopitaux De Marseille:

Primary Outcome Measures:
  • Quality of life [ Time Frame: one day ]

Estimated Enrollment: 100
Study Start Date: January 2017
Estimated Study Completion Date: March 2018
Estimated Primary Completion Date: January 2018 (Final data collection date for primary outcome measure)
  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   Child, Adult, Senior
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population
subject who experienced a near death experience (NDE).
Criteria

Inclusion Criteria:

  • Subject who experienced an NDE defined by the occurrence, when the subject is in a state of clinical death or a particular state of consciousness of a following event: body output experience, disembodiment, for a tunnel and / or light;
  • Topic recorded in the EMI database (Dr. Postel, National Center for Education, Research and Information on the conscience;
  • Topic agreeing to participate in the study.

Exclusion Criteria:

  • Patient mental condition or disorder or psychiatric history or any other factor limiting the ability to participate in an informed manner and compliant to the study;
  • Other than obtained Participation Agreement.
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02854930


Contacts
Contact: Anne Donnet 0491382747 drci@ap-hm.fr

Locations
France
Assistance Publique Hôpitaux de Marseille Hôpital de la Timone Not yet recruiting
Marseille, France, 13354
Contact: Anne Donnet    0491382747    drci@ap-hm.fr   
Sponsors and Collaborators
Assistance Publique Hopitaux De Marseille
Investigators
Study Director: Urielle Desalbres Assistance Publique Hôpitaux de Marseille
  More Information

Responsible Party: Assistance Publique Hopitaux De Marseille
ClinicalTrials.gov Identifier: NCT02854930     History of Changes
Other Study ID Numbers: 2014-47
First Submitted: August 1, 2016
First Posted: August 4, 2016
Last Update Posted: August 4, 2016
Last Verified: August 2016

Keywords provided by Assistance Publique Hopitaux De Marseille:
Clinical death
state of consciousness

Additional relevant MeSH terms:
Migraine Disorders
Death
Headache Disorders, Primary
Headache Disorders
Brain Diseases
Central Nervous System Diseases
Nervous System Diseases
Pathologic Processes